Dandamudi Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-05-2024
- Paid Up Capital ₹ 0.10 M
as on 28-05-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Dandamudi Biotech
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dandamudi Kumar and Suzanne Franklin serve as directors at the Company.
- CIN/LLPIN
U24290TG2021PTC152096
- Company No.
152096
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dandamudi Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dandamudi Kumar  | Director | 08-Jun-2021 | Current |
| Suzanne Franklin | Director | 08-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Dandamudi Biotech.
Enhance accessibility to Dandamudi Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dandamudi Biotech?
Unlock access to Dandamudi Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Magha Infra Development Private LimitedActive 12 years 7 monthsDandamudi Kumar and Suzanne Franklin are mutual person
- Dhatri & Dhanvi Projects Private LimitedActive 2 years 5 months
Dandamudi Kumar and Suzanne Franklin are mutual person
- Sjf Holdings Private LimitedActive 12 years 7 months
Dandamudi Kumar and Suzanne Franklin are mutual person
- Sri Balajisai Developers And Builders Private LimitedActive 1 year 6 months
Dandamudi Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dandamudi Biotech?
Dandamudi Biotech has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dandamudi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dandamudi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
